None gains: On U.S. withdrawal from WHO

The U.S. stands to lose by withdrawing from the WHO; it will forego health intelligence

July 10, 2020 12:15 am | Updated 11:01 am IST

On July 6, when the number of novel coronavirus cases and deaths in the U.S. reached over 2.8 million and nearly 0.13 million, respectively, the U.S. officially notified the United Nations of its intention to withdraw membership from the World Health Organization . This comes after President Donald Trump announced on May 29 his decision to halt funding and pull out of the global health body. After accusing WHO of being “China-centric” on multiple occasions, this unfortunate development is one more attempt by Mr. Trump to deflect blame for gross mismanagement of the crisis. In a May 18 letter, he officially demanded that the WHO make “major substantive improvements ” in 30 days while charging that the global body lacked “independence” from China, was slow to respond to the threat, and had “repeatedly made inaccurate or misleading claims” about the virus. Since the decision has apparently been taken without the approval of Congress, and as the withdrawal will become effective only on July 6 next year, there is a possibility that Congress or courts might reverse the withdrawal. Already, Democratic challenger Joe Biden has promised to revoke it if elected President. There is much at stake and unsurprisingly Congress is already under pressure from academia and medical associations to reject the withdrawal. The capricious decision to withdraw from WHO will have dire consequences for global public health. The departure of the U.S. will be a significant blow to the WHO in terms of loss of technical expertise and, according to Mr. Trump, an annual funding of about $450 million.

The pandemic has clearly brought to the fore several shortcomings and weaknesses in the global health body. For instance, the 2005 revision of the International Health Regulations made it mandatory for countries to notify the WHO of all events that may constitute an international public health emergency and to “respond to requests for verification of information regarding such events”. Yet, the WHO has limited power to ensure compliance by member States, including limitations in independently verifying member states’ official reports. If the U.S. was majorly involved in the 2005 IHR revision, it will now have no role to play in strengthening the WHO. It will lose a seat at the table to determine the virus strain to be used for developing influenza vaccines (flu killed over 34,000 people in the U.S. in 2018-19), and have no access to new influenza virus samples for research. With no more U.S. scientists embedded in the WHO in key roles, including outbreak response teams like the one that visited Wuhan, it will lose out on health intelligence that will compromise the country’s response to international disease outbreaks. In the end, none gains from a further weakened WHO.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.